Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Rifampicin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 214Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    J&J's tuberculosis Sirturo lands full US, EU approvals
    J&J's tuberculosis Sirturo lands full US, EU approvals

    08 Jul 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/jjs-tuberculosis-med-sirturo-lands-full-us-european-approvals-after-more-decade

    FIERCE PHARMA
    08 Jul 2024
    Share Share
    NPPA invokes Para 3 of DPCO to direct Macleods to supply anti-TB drug to CMSS
    NPPA invokes Para 3 of DPCO to direct Macleods to supply anti-TB drug to CMSS

    15 Jun 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=169748&sid=1

    PHARMABIZ
    15 Jun 2024
    Share Share
    Enforcement Report - Week of April 17, 2024
    Enforcement Report - Week of April 17, 2024

    17 Apr 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-17-2024-82633.pdf

    FDA
    17 Apr 2024
    Share Share
    Lupin, Glenmark recall drugs in US market: USFDA
    Lupin, Glenmark recall drugs in US market: USFDA

    10 Apr 2024

    // MONEYCONTROL

    https://www.moneycontrol.com/news/business/lupin-glenmark-recall-drugs-in-us-market-usfda-12613191.html

    MONEYCONTROL
    10 Apr 2024
    Share Share
    Enforcement Report - Week of February 7, 2024
    Enforcement Report - Week of February 7, 2024

    07 Feb 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-7-2024-67267.pdf

    FDA
    07 Feb 2024
    Share Share
    Fighting tuberculosis: EUROAPI’s rifampicin API meets new requirements for nitrosamine impurity standards
    Fighting tuberculosis: EUROAPI’s rifampicin API meets new requirements for nitrosamine impurity standards

    24 Oct 2023

    // PRESS RELEASE

    https://www.euroapi.com/en/fighting-tuberculosis-EUROAPI-rifampicin-meets-new-requirements-for-nitrosamine-impurity-standards

    PRESS RELEASE
    24 Oct 2023
    Share Share